Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis

Journal of Endocrinological Investigation

Volumn 33, Issue 5, 2010, Pages 347-352

  Fusaro, M ^a   D'Angelo, A ^a   Scalzo, G ^b   Gallieni, M ^c   Giannini, S ^a   Guglielmi, G ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Chronic renal insufficiency; Dialysis; Osteoporotic fractures; Renal osteodystrophy; Vascular calcifications; Vertebral fractures

Indexed keywords

BLOOD VESSEL CALCIFICATION; BONE MASS; BONE TURNOVER; CHRONIC KIDNEY DISEASE; DIALYSIS; ENDOCRINE DISEASE; HUMAN; REVIEW; RISK FACTOR; VERTEBRA FRACTURE;

EID: 77954206963     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346598     Document Type: Review

References (67)

1. Moe S, Drüeke T, Cunningham J, et al; Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney lnt 2006, 69: 1945-53.
2. Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 2002, 17: 2094-105. (Pubitemid 35416745)
3. Lirenman DS, Price JD, Lauener RW, Miller HS. Renal osteodystrophy during hemodialysis for chronic renal failure. Canad Med Ass J 1968, 99: 668-74.
4. Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet 1979, 24: 406-9.
5. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999, 33: 287-93. (Pubitemid 29072230)
6. Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M, et al. Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex. Nefrologia 2003, 23 (Suppl 2): 106-11.
7. Alem AM, Sherrard DJ, Gillen DL, et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney lnt 2000, 58: 396-9.
8. Jadoul M, Albert JM, Akiba T, et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney lnt 2006, 70: 1358-66. (Pubitemid 44435190)
9. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8: 1137-48.
10. Guglielmi G, Diacinti D, van Kuijk C, et al. Vertebral morphometry: current methods and recent advances. Eur Radiol 2008, 18: 1484-96.
11. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1999, 14: 821-8.
12. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001, 285: 320-3.
13. Link TM, Guglielmi G, van Kuijk C, Adams JE. Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications. Eur Radiol 2005, 15: 1521-32.
14. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996, 11:984-96.
15. Guglielmi G, Palmieri F, Placentino MG, D'Errico F, Stoppino LP. Assessment of osteoporotic vertebral fractures using specialized workflow software for 6-point morphometry. Eur J Radiol 2009, 70: 142-8.
16. Guglielmi G, Stoppino LP, Placentino MG, D'Errico F, Palmieri F. Reproducibility of a semi-automatic method for 6-point vertebral morphometry in a multi-centre trial. Eur J Radiol 2009, 69: 173-8.
17. Diacinti D, Guglielmi G, Tomei E, et al. Vertebral morphometry: evaluation of osteoporosis-caused fractures. Radiol Med 2001, 101: 140-4.
18. Diacinti D, Pisani D, Barone-Adesi F, et al. A new predictive index for vertebral fractures: The sum of the anterior vertebral body heights. Bone 2010, 46: 768-73.
19. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 2002, 17: 2222-30.
20. Cunningham J, Sprague SM, Cannata-Andia J, et al; Osteoporosis Work Group. Osteoporosis in chronic kidney disease. Am J Kidney Dis 2004, 43: 566-71.
21. Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S. Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 1996, 19: 549-55.
22. Ureña P, Bernard-Poenaru O, Ostertag A, et al. Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 2003, 18: 2325-31. (Pubitemid 37345093)
23. Duan Y, De Luca V, Seeman E. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 1999, 84: 718-22. (Pubitemid 29075711)
24. Guglielmi G, Grimston SK, Fischer KC, Pacifici R. Lateral and posterior-anterior dual X-ray absorptiometry: comparison with quantitative computed tomography in the diagnosis of osteoporosis. Radiology 1994, 192: 845-50.
25. Guglielmi G. Quantitative computed tomography (QCT) and dual X-ray absorptiometry (DXA) in the diagnosis of osteoporosis. Eur J Radiol 1995, 20: 185-7.
26. Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990, 70: 1202-7. (Pubitemid 20138649)
27. Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA. Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 2002, 39: 843-9.
28. Di Leo C, Tarolo GL, Bestetti A, et al. Assessment of geometric, biomechanical, and osteodensitometric properties of the ultradistat radius with peripheral quantitative computerized tomography in uremic patients with severe hyperparathyroidism. Radiol Med 1999, 97: 229-35.
29. Guglielmi G, De Serio A, Fusilli S, et al. Age-related changes assessed by peripheral QCT in healthy Italian women. Eur Radiol 2000, 10: 609-14.
30. Hasegawa K, Hasegawa Y, Nagano A. Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography. J Biomech 2004, 37: 751-6.
31. Jamal SA, Gilbert J, Gordon C, et al. Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 2006, 21: 543-8.
32. Mares J, Ohlidalova K, Opatma S, Ferda J. Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients. J Bone Miner Metab 2009, 27: 217-23.
33. Wüster C, Albanese C, De Aloysio D, et al. Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res 2000, 15: 1603-14.
34. Glüer CC, Eastell R, Reid DM, et al. Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS study. J Bone Miner Res 2004, 19: 782-93.
35. Montagnani A, Gonnelli S, Cepollaro C, et al. Quantitative ultrasound in the assessment of skeletal status in uremic patients. J Clin Densitom 1999, 2: 389-95.
36. Rico H, Aguado F, Revilla M, Villa LF, Martin J. Ultrasound bone velocity and metacarpal radiogrametry in hemodialyzed patients. Miner Electrolyte Metab 1994, 20: 103-6.
37. Przedlacki J, Pluskiewicz W, Wieliczko M, et al. Quantitative ultrasound of phalanges and dual-energy X-ray absorptiometry of forearm and hand in patients with end-stage renal failure treated with dialysis. Osteoporosis lnt 1999, 10: 1-6.
38. Guglielmi G, Adams J, Link TM. Quantitative ultrasound in the assessment of skeletal status. Eur Radiol 2009, 19: 1837-48.
39. Pluskiewicz W, Adamczyk P, Drozdzowska B, et al. Skeletal status in children, adolescents and young adults with end-stage renal failure treated with hemo- or peritoneal dialysis. Osteoporosis lnt 2002, 13: 353-7. (Pubitemid 34625390)
40. Pluskiewicz W, Przedlacki J, Drozdzowska B, Wtodarczyk D, Matuszkiewicz-Rowinska J, Adamczyk P. Quantiative ultrasound at hand phalanges in adults with end-stage renal failure. Ultrasound Med Biol 2004, 30: 455-9. (Pubitemid 38581145)
41. Guglielmi G, de Terlizzi F, Aucella F, Scillitani A. Quantitative ultrasound technique at the phalanges in discriminating between uremic and osteoporotic patients. Eur J Radiol 2006, 60: 108-14. (Pubitemid 44397378)
42. Davis K, Aslam, Pejovic-Milic A, Chettle DR. In vivo measurement of bone aluminum in population living in southern Ontario, Canada. Med Phys 2008, 35: 5115-23.
43. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney lnt Suppl 2009, 113: S1-130
44. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos lnt 2008, 19: 385-97.
45. Stehman-Breen CO, Sherrard DJ, Alem AM, et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney lnt 2000, 58: 2200-5.
46. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15: 2208-18.
47. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 2000, 36: 1115-21.
48. Rudser KD, De Boer IH, Dooley A, et al. Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 2007, 18: 2401-7.
49. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (Suppl 3): S1-201.
50. Mucsi I, Almási C, Deák G, et al. Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephrol 2005, 64: 288-94.
51. Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009, 13: 268-72.
52. Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004, 350: 2033-41.
53. Jamal SA, Leiter RE, Bauer DC. Hyperhomocysteinaemia and aortic calcification are associated with fractures in patients on haemodialysis. QJM 2005, 98: 575-9.
54. Rodríguez-García M, Naves-Díaz M, Cannata-Andía J. Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence. J Nephrol 2005, 18: 458-63.
55. Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 2006, 47: 149-56.
56. Rodríguez-García M, Gómez-Alonso C, Naves-Díaz M, Diaz-Lopez JB, Diaz-Corte C, Cannata-Andía JB; Asturias Study Group. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients. Nephrol Dial Transplant 2009, 24: 239-46.
57. Schousboe JT, Wilson KE, Kiel DP. Detection of abdominal aortic calcification with lateral spine imaging using DXA. J Clin Densitom 2006, 9: 302-8.
58. Cunningham J, Danese M, Olson K, et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney lnt 2005, 68: 1793-800.
59. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001, 21: 817-24.
60. Nitta K, Akiba T, Suzuki K, et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004, 44: 680-8.
61. Bergner R, Henrich D, Hoffmann M, et al. Treatment of reduced bone density with ibandronate in dialysis patients. J Nephrol 2008, 21: 510-6.
62. Miller PD. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease. Curr Osteoporos Rep 2005, 3: 5-12.
63. Cockayne S, Adamson J, Lanham-New S, et al. Vitamin K and prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2006, 166: 1256-61.
64. Nakashima A, Yorioka N, Doi S, et al. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone level. Bone 2004, 34: 579-83.
65. Guglielmi G, Andreula C, Muto M, Gilula LA. Percutaneous vertebroplasty: indications, contraindications, technique, and complications. Acta Radiol 2005, 46: 256-68.
66. Muto M, Perrotta V, Guamieri G, et al. Vertebroplasty and kyphoplasty: friends or foes? Radiol Med 2008, 113: 1171-84.
67. Wagner AL, Baskurt E. Refracture with cement extrusion following percutaneous vertebroplasty of a large interbody cleft. AJNR Am J Neuroradiol 2006, 27: 230-1.